Changes in the management of children with Cystic Fibrosis
Caroline Murphy & Deirdre O’Donovan CF Nurses
Changes in the management of children with Cystic Fibrosis Caroline - - PowerPoint PPT Presentation
Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre ODonovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects the lungs and digestive
Changes in the management of children with Cystic Fibrosis
Caroline Murphy & Deirdre O’Donovan CF Nurses
Cystic fibrosis (CF) is an inherited chronic disease that primarily affects the lungs and digestive system of about 1200 children and adults in Ireland (70,000 worldwide). In Cork, the Paediatric population is 100, the Adult population is 170. A defective gene and its protein product cause the body to produce unusually thick, sticky secretions which causes
The fluid lining in the airways to be reduced, resulting in excess sticky secretions that are prone to infection and difficult to expectorate
In the pancreas, the sticky secretions block the flow of digestive juices into the gut leading to impaired digestion and poor absorption of food
Aim of NBS is early diagnosis before presentation with respiratory
symptoms and malabsorption.
Introduced in July 2011 Heel Prick test 6 designated CF centres First phone call contact by CF Nurse to parents
2 4 6 8 10 12 14 16 18 July 11- 12 July 12 - 13 July 13-14 July 14-15 July 15- 16 July 16-17 diagnosis Calls
About 50 new cases of Cystic Fibrosis in Ireland are diagnosed each year. Because of new born screening, most babies with CF should now be diagnosed
quickly
Around 55% of the CF patient population in Ireland is aged 18 or older. Today, advances in research and medical treatments have further enhanced and
extended life for children and adults with CF. Many people with the disease in Ireland can now expect to live into their 30s, 40s and beyond.
Aim to maintain an appropriate weight above the 50TH centile Appropriate weight tends to correlates with good pulmonary function 95% of CF patients are pancreatic insufficient Creon is the pancreatic enzyme given to aid absorption of fats. Stools should be monitored by parents, if stools are oily this means creon
needs to be adjusted by the dietician
Fat soluble vitamins A,D,E,K are supplemented. Levels are checked
annually
Calcium supplements maybe required to prevent osteoporosis- bone
density scan every 5yrs.
High fat diet maybe required depending on BMI. Nutritional supplements e.g Calogen, Fortisip, Shakes Enteral feeds (PEG) if low BMI and FTT
Appetite stimulants H2 antagonists and proton pump inhibitors CF patients are at risk of Distal Intestinal Obstruction Syndrome
(DIOS) and constipation.
CF Patients may develop Cystic Fibrosis Related Diabetes (CFRD) Increased salt intake in hot weather and avoid dehydration
Past
precussion
Present
Excessive mucus secretion
Mucus stagnation infection
Inflammation
Lung damage
PO/IV antibiotics Nebulised mucolytics Nebulised antibiotics +/- steroids +/- antifungals Genetic modifiers
Microbiology is fundamental to CF management
Most commonly cultured organisms:
Staph aureus
Haemophilus influenzae
Pseudomonas Aeruginosa – chronic conolisation
Aspergillus
Non tubercular mycobacteria
Antimicrobials are decided by what is cultured on throat swab or sputum if a child is symptomatic
Preventing bacterial acquisition & minimising cross infection
Single en-suite room No sharing of toilets as inpatient or
at clinic
Avoid interaction with other CF
patients
Bring own medical devices Hospital Segregation policies High standard of hand hygiene
must be practiced by healthcare professionals